Compare AU

Compare VAS vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Vanguard Australian Shares Index ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Australian Shares Index ETF (VAS) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

VAS

DRUG

Popularity

High

Low

Pearlers invested

18,379

63

Median incremental investment

$1,003.21

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$2,922.08

$1,921.92

Average age group

26 - 35

26 - 35


Key Summary

VAS

DRUG

Strategy

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX).

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

BHP Group Ltd. (10.36 %)

Commonwealth Bank of Australia (7.92 %)

CSL Ltd. (5.76 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Financials (27.66 %)

Materials (23.74 %)

Health Care (8.77 %)

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

Australia (94.56 %)

United States (3.02 %)

New Zealand (1.65 %)

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.07 %

0.57 %


Key Summary

VAS

DRUG

Issuer

Vanguard

BetaShares

Tracking index

S&P/ASX 300 Index - AUD

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.07 %

0.57 %

Price

$103.88

$8.25

Size

N/A

$182.401 million

10Y return

55.88 %

N/A

Annual distribution yield (5Y)

5.52 %

1.90 %

Market

ASX

ASX

First listed date

08/05/2009

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

VAS

DRUG

Popularity

High

Low

Pearlers invested

18,379

63

Median incremental investment

$1,003.21

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$2,922.08

$1,921.92

Average age group

26 - 35

26 - 35


Pros and Cons

VAS

DRUG

Pros

  • Higher exposure to AU market

  • Lower management fee

  • Higher distribution yield

  • Higher exposure to US market

  • Higher price growth

Cons

  • Lower exposure to US market

  • Lower price growth

  • Lower exposure to AU market

  • Higher management fee

  • Lower distribution yield

VAS

DRUG

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home